Voriconazole potentiates warfarin-induced prothrombin time prolongation.

Abstract:

AIMS:Voriconazole is a novel triazole with broad-spectrum antifungal activity. It is likely that some patients receiving voriconazole may also require treatment with the anticoagulant warfarin. Cytochrome P450 isoenzymes are important in the metabolism of both these drugs. This study investigated the effect of voriconazole on the pharmacodynamics of warfarin by measuring prothrombin time, and also evaluated the safety and tolerability of the coadministered drugs. METHODS:This was a double-blind, placebo-controlled, two-way crossover study in which healthy male subjects received either 300 mg voriconazole or placebo twice daily on days 1-12, plus a single oral dose of 30 mg warfarin on day 7 of each study period. Volunteers were randomized to one of the following treatment sequences: voriconazole + warfarin followed by placebo + warfarin or placebo + warfarin followed by voriconazole + warfarin. There was a washout of at least of 7 days between treatment periods. RESULTS:The mean Cmax, AUCtau and tmax for voriconazole were 3736 ng ml-1, 25 733 ng.h ml-1, and 1.66 h, respectively. Both the mean maximum change from baseline prothrombin time and the mean area under the effect curve (AUEC) for prothrombin time during coadministration with voriconazole (17 s and 3211 s.h, respectively) were statistically significantly greater than the mean values observed during the placebo period (8 s and 2282 s.h ). Prothrombin times were still increased by a mean value of 5.4 s 144 h post warfarin dose following coadministration with voriconazole compared with a mean value of 0.6 s in the placebo treatment period. CONCLUSIONS:Coadministration of voriconazole and warfarin potentiates warfarin-induced prothrombin time prolongation. Regular monitoring of prothrombin time is recommended if these drugs are coadministered, with appropriate adjustment of the dose of warfarin.

journal_name

Br J Clin Pharmacol

authors

Purkins L,Wood N,Kleinermans D,Nichols D

doi

10.1046/j.1365-2125.2003.01995.x

keywords:

subject

Has Abstract

pub_date

2003-12-01 00:00:00

pages

24-9

eissn

0306-5251

issn

1365-2125

pii

1995

journal_volume

56 Suppl 1

pub_type

临床试验,杂志文章,随机对照试验
  • Effect of multiple doses of montelukast on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in humans.

    abstract:AIMS:To investigate the effect of multiple dosing with montelukast, a selective leukotriene-receptor antagonist, on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in humans. METHODS:A two-period, randomized crossover study was conducted in 10 healthy subjects. After administration of oral doses of placebo ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.2006.02764.x

    authors: Kim KA,Park PW,Kim KR,Park JY

    更新日期:2007-03-01 00:00:00

  • Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria.

    abstract::Twelve patients with acute uncomplicated falciparum malaria were admitted to the Hospital for Tropical Diseases for 42 days. The patients were treated with halofantrine 500 mg 6 hourly for three doses and halofantrine and its desbutyl metabolite were analysed in plasma by h.p.l.c. Cmax values of halofantrine and desbu...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1991.tb05567.x

    authors: Karbwang J,Milton KA,Na Bangchang K,Ward SA,Edwards G,Bunnag D

    更新日期:1991-04-01 00:00:00

  • Inhaled histamine increases the rate of absorption of sodium cromoglycate from the lung.

    abstract::Since many factors may alter lung epithelial permeability (LEP) to water soluble molecules, the effect of histamine on the absorption and clearance of inhaled sodium cromoglycate was examined in seven mildly asthmatic patients with hyperresponsive airways and eight normal subjects. The subjects underwent histamine cha...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1365-2125.1992.tb04048.x

    authors: Richards R,Fowler C,Simpson S,Renwick AG,Holgate ST

    更新日期:1992-03-01 00:00:00

  • Lack of inhibitory effect of metronidazole on theophylline disposition in healthy subjects.

    abstract::The effect of metronidazole, at a dose of 1.2 g daily, on theophylline disposition was studied in 10 healthy adult volunteers. Neither theophylline half-life, volume of distribution nor total body clearance was altered by the anti-microbial. It is concluded that metronidazole does not impair theophylline metabolism de...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1987.tb03146.x

    authors: Adebayo GI,Mabadeje AF

    更新日期:1987-07-01 00:00:00

  • Pharmacokinetics of physostigmine in man following a single application of a transdermal system.

    abstract::1. The pharmacokinetics of physostigmine were investigated in a three-way cross-over design in six healthy, male volunteers comparing a physostigmine transdermal system (PTS), an oral solution and an i.v. infusion. 2. A single application of the patch over 24 h produced detectable plasma drug concentrations after a me...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1995.tb04410.x

    authors: Walter K,Müller M,Barkworth MF,Nieciecki AV,Stanislaus F

    更新日期:1995-01-01 00:00:00

  • Effects of a geriatric intervention aiming to improve quality care in nursing homes on benzodiazepine use and discontinuation.

    abstract:BACKGROUND:Benzodiazepines and "Z drugs" are often prescribed in residents of nursing homes (NH) despite their well-known deleterious effects. We aimed to investigate if a general intervention on quality of care led to discontinuation of benzodiazepine, and to examine which NH-related factors were associated in change ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/bcp.12847

    authors: de Souto Barreto P,Lapeyre-Mestre M,Cestac P,Vellas B,Rolland Y

    更新日期:2016-04-01 00:00:00

  • Interaction between midazolam and clarithromycin in the elderly.

    abstract:AIM:To assess the relative contribution of intestinal and hepatic CYP3A inhibition to the interaction between the prototypic CYP3A substrate midazolam and clarithromycin in the elderly. METHODS:On day 1, 16 volunteers (eight male, eight female) aged 65-75 years weighing 59-112 kg received simultaneous doses of midazol...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1365-2125.2007.02970.x

    authors: Quinney SK,Haehner BD,Rhoades MB,Lin Z,Gorski JC,Hall SD

    更新日期:2008-01-01 00:00:00

  • Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine.

    abstract:WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT:Rotigotine transdermal patch is a new non-ergolinic dopamine agonist developed for the treatment of Parkinson's disease and restless legs syndrome. Peripheral dopaminergic side-effects of dopamine agonists such as nausea and vomiting can be prevented by the antiemetic agent domp...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.2008.03334.x

    authors: Braun M,Cawello W,Boekens H,Horstmann R

    更新日期:2009-02-01 00:00:00

  • Acute management of severe hypertension with oral labetalol.

    abstract::1 Six previously untreated emergency admissions to hospital with severe hypertension were given oral treatment with labetalol. 2 Pre-treatment diastolic BP exceeded 130 mmHg, and clinical evidence of either accelerated hypertension or encephalopathy was present. 3 Hypotensive response after treatment followed two patt...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:

    authors: Ghose RR

    更新日期:1979-01-01 00:00:00

  • Lead poisoning: case studies.

    abstract::Early clinical features of lead toxicity are non-specific and an occupational history is particularly valuable. Lead in the body comprises 2% in the blood (t1/2 35 days) and 95% in bone and dentine (t1/2 20-30 years). Blood lead may remain elevated for years after cessation from long exposure, due to redistribution fr...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2125.2002.01580.x

    authors: Gordon JN,Taylor A,Bennett PN

    更新日期:2002-05-01 00:00:00

  • Management of Helicobacter pylori eradication--the influence of structured counselling and follow-up.

    abstract:AIMS:Helicobacter pylori (H. pylori) eradication rate varies according to the treatment regimen used and other factors, e.g. antimicrobial resistance and patient compliance. The aim of the present study was to evaluate the influence of patient counselling and follow-up on H. pylori eradication rates and to document the...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1046/j.0306-5251.2001.01531.x

    authors: Al-Eidan FA,McElnay JC,Scott MG,McConnell JB

    更新日期:2002-02-01 00:00:00

  • Lack of interaction between nefazodone and cimetidine: a steady state pharmacokinetic study in humans.

    abstract::The steady-state pharmacokinetic interaction between nefazodone and cimetidine was evaluated in a three-period crossover study consisting of three treatments of 1 week duration with a 1 week washout between treatments. The 18 healthy, male study subjects received: nefazodone hydrochloride 200 mg twice daily (every 12 ...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1995.tb05771.x

    authors: Barbhaiya RH,Shukla UA,Greene DS

    更新日期:1995-08-01 00:00:00

  • Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone.

    abstract::1. The pharmacokinetics of proguanil were evaluated in patients with acute P. falciparum malaria receiving concomitantly proguanil hydrochloride and atovaquone. The population consisted of 203 Blacks, 112 Orientals and 55 Malays; 274 males and 96 females. Of the 370 patients, 114 and 256 patients were classified as 'p...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1996.tb00114.x

    authors: Hussein Z,Eaves CJ,Hutchinson DB,Canfield CJ

    更新日期:1996-11-01 00:00:00

  • Do statins protect against upper gastrointestinal bleeding?

    abstract:AIMS:Recently, an apparent protective effect of statins against upper gastrointestinal bleeding (UGB) was postulated in a post hoc analysis of a randomized trial. We aimed to evaluate the effect of statin use on acute nonvariceal UGB alone or in combinations with low-dose aspirin and other antithrombotic drugs. METHOD...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.2009.03362.x

    authors: Gulmez SE,Lassen AT,Aalykke C,Dall M,Andries A,Andersen BS,Hansen JM,Andersen M,Hallas J

    更新日期:2009-04-01 00:00:00

  • New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs.

    abstract::Despite the revolution in recent decades regarding monoamine involvement in the management of major depressive disorder (MDD), the biological mechanisms underlying this psychiatric disorder are still poorly understood. Currently available treatments require long time courses to establish antidepressant response and a ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1111/bcp.12845

    authors: Ignácio ZM,Réus GZ,Arent CO,Abelaira HM,Pitcher MR,Quevedo J

    更新日期:2016-11-01 00:00:00

  • Chenodeoxycholic acid therapy for hypertriglyceridaemia in men.

    abstract::1 Ten consecutive patients with hypertriglyceridaemia who adhered to a low carbohydrate diet without complete control of serum triglycerides were started on chenodeoxycholic acid 750 mg daily and followed monthly for 6 months. Nine of these patients were then followed for a further month on placebo capsules and therea...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1365-2125.1978.tb01632.x

    authors: Bateson MC,Maclean D,Evans JR,Bouchier IA

    更新日期:1978-03-01 00:00:00

  • Efficacy gap between phase II and subsequent phase III studies in oncology.

    abstract:AIMS:There is a trend for more flexibility in timing of evidence generation in relation to marketing authorization, including the option to complete phase III trials after authorization or not at all. This paper investigated the relation between phase II and III clinical trial efficacy in oncology. METHODS:All oncolog...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/bcp.14237

    authors: Vreman RA,Belitser SV,Mota ATM,Hövels AM,Goettsch WG,Roes KCB,Leufkens HGM,Mantel-Teeuwisse AK

    更新日期:2020-07-01 00:00:00

  • Lack of interaction between valaciclovir, the L-valyl ester of aciclovir, and digoxin.

    abstract:AIMS:Changes in both digoxin and aciclovir renal clearance following coadministration with some other renally eliminated drugs have been reported. The potential interaction of valaciclovir, with its antiherpetic metabolite aciclovir, and digoxin was investigated. METHODS:Twelve healthy volunteers (seven males, five fe...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1046/j.1365-2125.1998.00649.x

    authors: Soul-Lawton JH,Weatherley BC,Posner J,Layton G,Peck RW

    更新日期:1998-01-01 00:00:00

  • The effect of oral dosing of xamoterol on systolic time intervals in man and xamoterol plasma concentrations in heart failure patients.

    abstract::1. Six healthy male human volunteers of mean age 30.8 years (range 23-37) were given single oral doses of xamoterol (20, 50, 100 or 250 mg) and placebo with a 1 week interval between each dose. Xamoterol produced a significant decrease in systolic time intervals (QS2I, LVETI and PEPI) and a significant increase in sys...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1990.tb03663.x

    authors: James MA,Papouchado M,Channer KS,Jones JV,Marlow HF,Bastain W,Barker NP,Harry JD,Wardleworth AG

    更新日期:1990-04-01 00:00:00

  • Growth factors for diabetic foot ulcers: mixed treatment comparison analysis of randomized clinical trials.

    abstract:AIMS:Topical growth factors accelerate wound healing in patients with diabetic foot ulcers (DFU). Due to the absence of head-to-head comparisons, we carried out Bayesian network meta-analysis to compare the efficacy and safety of growth factors. METHODS:Using an appropriate search strategy, randomized controlled trial...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,meta分析

    doi:10.1111/bcp.13470

    authors: Sridharan K,Sivaramakrishnan G

    更新日期:2018-03-01 00:00:00

  • Impact of spironolactone exposure on prostate cancer incidence amongst men with heart failure: A Pharmacoepidemiological study.

    abstract:AIMS:Aldosterone has been found to influence cancer cell growth, cell cycle regulation and cell migration, including in prostate cancer cells. Spironolactone is an aldosterone antagonist used for managing chronic heart failure (HF) with known antiandrogenic effects. We examined the effect of spironolactone exposure amo...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/bcp.14568

    authors: Hiebert BM,Janzen BW,Sanjanwala RM,Ong AD,Feldman RD,Kim JO

    更新日期:2020-09-28 00:00:00

  • Inhibition of human liver cytochrome P-450 by omeprazole.

    abstract::The effects of omeprazole on cytochrome P-450 mediated 7-ethoxycoumarin deethylation were studied in human liver microsomes. Omeprazole inhibited both the high and low affinity components of deethylation, with an estimated Ki of 0.03 mM for the high affinity component. The results are further evidence that the previou...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1986.tb05199.x

    authors: Jensen JC,Gugler R

    更新日期:1986-03-01 00:00:00

  • Lithium does not alter the renal response to a pressor dose of tyramine in man.

    abstract::Renal clearance of lithium has been used as a marker of proximal tubular function in man. Recently, lithium pre-treatment has been shown to interfere with the natriuretic actions of some natriuretic agents in man. We have therefore investigated the effects of oral lithium carbonate (500 mg) on the natriuretic response...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1991.tb05598.x

    authors: Lang CC,Rahman AR,Struthers AD

    更新日期:1991-06-01 00:00:00

  • Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years old.

    abstract:AIMS:Major bleeding complications with low-molecular-weight heparin (LMWH) treatment have been reported both in clinical studies and during postmarketing surveillance. Monitoring of antifactor Xa (anti-Xa) activities is therefore recommended in special populations often predisposed to renal impairment. The PROPHRE.75 s...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.2007.02920.x

    authors: Berges A,Laporte S,Epinat M,Zufferey P,Alamartine E,Tranchand B,Decousus H,Mismetti P,PROPHRE.75 Study Group.

    更新日期:2007-10-01 00:00:00

  • Lisinopril: dose-peak effect relationship in essential hypertension.

    abstract::1. The dose-peak effect relationship of lisinopril was evaluated in a double-blind, parallel study in 83 patients with mild to moderate essential hypertension (supine diastolic blood pressure = 95-115 mm Hg). 2. After a 4 week placebo washout, patients were randomly assigned to one of four treatments: lisinopril 2.5, ...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1988.tb03342.x

    authors: Cirillo VJ,Gomez HJ,Salonen J,Salonen R,Rissanen V,Bolognese JA,Nyberg R,Kristianson K

    更新日期:1988-05-01 00:00:00

  • Effect of valpromide on the pharmacokinetics of carbamazepine-10, 11-epoxide.

    abstract::The single oral dose pharmacokinetics of carbamazepine-10, 11-epoxide (CBZ-E) were investigated in six normal volunteers during a control session and during concurrent treatment with valpromide (VPM) (300 mg twice daily for 8 days). VPM caused a prolongation of the CBZ-E half-life from 6.4 +/- 1.4 to 20.5 +/- 6.3 h an...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1988.tb03354.x

    authors: Pisani F,Fazio A,Oteri G,Spina E,Perucca E,Bertilsson L

    更新日期:1988-05-01 00:00:00

  • Influence of chronic dosing on theophylline clearance.

    abstract::Theophylline clearance was studied in normal healthy volunteers before and after chronic oral dosing. Oral theophylline clearance showed a significant decrease (P less than 0.001) from 59.3 +/- 6.48 ml/min (mean +/- s.e. mean, n = 10) to 48.0 +/- 6.4 ml/min. Steady-state intravenous clearance decreased by 26 +/- 2% fr...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1984.tb02385.x

    authors: Efthimiou H,Morgan DJ,Ioannides-Demos L,Raymond K,McLean AJ

    更新日期:1984-05-01 00:00:00

  • Ouabain and responses to endothelium-dependent vasodilators in the human forearm.

    abstract::Ouabain inhibits endothelium-dependent vascular relaxation in vitro, but has not been studied in this regard in vivo. We have therefore measured blood flow responses to carbachol, bradykinin and sodium nitroprusside (endothelium-dependent and endothelium-independent vasodilators) infused into the brachial artery with ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:

    authors: Woolfson RG,Benjamin N,Todd SD,Poston L,Ritter JM

    更新日期:1991-12-01 00:00:00

  • Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour?

    abstract:AIMS:The main goal of the study was to describe the pharmacokinetics of maternal zidovudine (ZDV) administration during pregnancy and labour and to evaluate their impact on fetal concentrations and exposures. METHODS:A total of 195 HIV-infected pregnant and non-pregnant women aged 16-59 years were included and 273 mat...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/bcp.12459

    authors: Fauchet F,Treluyer JM,Valade E,Benaboud S,Pannier E,Firtion G,Foissac F,Bouazza N,Urien S,Hirt D

    更新日期:2014-12-01 00:00:00

  • Pharmacokinetics of piroximone after oral and intravenous administration to patients with renal insufficiency.

    abstract::The pharmacokinetics of piroximone (PI) were determined in patients with renal failure (inulin clearance less than 50 ml min-1 per 1.73 m2) using two protocols: (a) 10 patients received a single i.v. infusion of 0.5 mg kg-1 PI and the data were compared with those from seven healthy subjects receiving the same regimen...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1995.tb04429.x

    authors: Fauvel JP,Bernard N,Laville M,Pozet N,Sassard J,Zech PY

    更新日期:1995-02-01 00:00:00